Our previous studies showed that some genetic features may influence disease susceptibility or anti-TNF therapy outcome in RA patients (Bogunia-Kubik et al. 2015; Gębura et al. 2017; Iwaszko et al. 2018; Świerkot et al. 2015a). The gene discussed is TNF; the disease is rheumatoid arthritis.